Min 49, "we need to make sure going forward we focus on share holder value and the OTC is just not the right place to do that from". So yeah it could mean a rs but I have the feeling it's not going to be bad if they even need to do it. Once MSP and Lympro show revenue by the 3rd Q our valuation could be through the roof just based of those two diag's.

Now on therapeutics, it sounds like he told BP and institutions to fuck off and bring me real offers, to me with regards to Eltoprazine. Look at 35:45- 36:30 was that a subliminal bird he flipped or was it on purpose? A branded product with a no competition...fuck you BP show me the money!! Is what I heard and saw there, hahaha...